FITC Anti-Human CD41 Antibody[HIP8]

The FITC Anti-Human CD41 Antibody[HIP8] is a highly specific and sensitive monoclonal antibody that has been designed for the detection of human CD41 antigen. This antibody is conjugated with fluorescein isothiocyanate (FITC) and is intended for use in flow cytometry and immunofluorescence applications.

The CD41 antigen is a glycoprotein that is expressed on the surface of platelets and megakaryocytes. It plays a crucial role in platelet aggregation and thrombus formation, making it an important target for research in the fields of hematology and thrombosis. The FITC Anti-Human CD41 Antibody[HIP8] has been extensively validated for its specificity and sensitivity in detecting CD41 antigen in human samples.

This antibody has been produced using hybridoma technology and is of the IgG1 isotype. It has a high affinity for the CD41 antigen and has been shown to bind to both resting and activated platelets. The FITC conjugation allows for easy detection of the antibody in flow cytometry and immunofluorescence assays, making it a valuable tool for researchers studying platelet function and thrombosis.

The FITC Anti-Human CD41 Antibody[HIP8] is supplied in a liquid form and is ready to use. It has been optimized for use in a variety of applications, including flow cytometry, immunofluorescence, and immunohistochemistry. It is recommended to use this antibody at a concentration of 1-5 μg/mL for flow cytometry and 5-10 μg/mL for immunofluorescence.

In summary, the FITC Anti-Human CD41 Antibody[HIP8] is a highly specific and sensitive monoclonal antibody that has been designed for the detection of human CD41 antigen. It is a valuable tool for researchers studying platelet function and thrombosis and is suitable for use in a variety of applications.